| human | Q5 |
| P6178 | Dimensions author ID | 01013646123.43 |
| P496 | ORCID iD | 0000-0001-6801-4431 |
| P1153 | Scopus author ID | 55660189000 |
| P69 | educated at | Case Western Reserve University | Q1047060 |
| P108 | employer | Massachusetts Institute of Technology | Q49108 |
| Charles Stark Draper Laboratory | Q2876029 | ||
| Case Western Reserve University | Q1047060 | ||
| The Schepens Eye Research Institute | Q54556346 | ||
| P734 | family name | McHugh | Q21484509 |
| McHugh | Q21484509 | ||
| McHugh | Q21484509 | ||
| P735 | given name | Kevin | Q605834 |
| Kevin | Q605834 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | male | Q6581097 |
| Q91271876 | A heat-stable microparticle platform for oral micronutrient delivery |
| Q33861493 | A novel porous scaffold fabrication technique for epithelial and endothelial tissue engineering |
| Q51738829 | Biocompatible Semiconductor Quantum Dots as Cancer Imaging Agents. |
| Q92094360 | Biocompatible near-infrared quantum dots delivered to the skin by microneedle patches record vaccination |
| Q91109125 | Chiral Supraparticles for Controllable Nanomedicine |
| Q34223021 | Combined surface micropatterning and reactive chemistry maximizes tissue adhesion with minimal inflammation. |
| Q64947708 | Computational modeling of retinal hypoxia and photoreceptor degeneration in patients with age-related macular degeneration. |
| Q95643289 | Employing drug delivery strategies to create safe and effective pharmaceuticals for COVID-19 |
| Q98499104 | Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy |
| Q57341500 | Evaporative Cooling Hydrogel Packaging for Storing Biologics Outside of the Cold Chain |
| Q48344306 | Fabrication of fillable microparticles and other complex 3D microstructures. |
| Q41983406 | Identification of a synergistic interaction between endothelial cells and retinal pigment epithelium |
| Q55175110 | Immunogenicity of pulsatile-release PLGA microspheres for single-injection vaccination. |
| Q43097131 | Layer-by-Layer Encapsulation of Probiotics for Delivery to the Microbiome |
| Q99407539 | Modeling, design, and machine learning-based framework for optimal injectability of microparticle-based drug formulations |
| Q51331766 | One-step synthesis, biodegradation and biocompatibility of polyesters based on the metabolic synthon, dihydroxyacetone. |
| Q123585131 | Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems |
| Q37671076 | Porous poly(ε-caprolactone) scaffolds for retinal pigment epithelium transplantation |
| Q38562819 | Single-injection vaccines: Progress, challenges, and opportunities |
| Q55473113 | Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response. |
| Q84575540 | The topographical effect of electrospun nanofibrous scaffolds on the in vivo and in vitro foreign body reaction |
| Q37048185 | Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release |
| Q38112654 | Topographical control of ocular cell types for tissue engineering. |
Search more.